chrisvoncsefalvay/vaers-outcomes huggingface dataset:
pain in neck, shoulders and back; pain in neck, shoulders and back; pain in neck, shoulders and back; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (pain in neck, shoulders and back), ARTHRALGIA (pain in neck, shoulders and back) and BACK PAIN (pain in neck, shoulders and back) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026G21A and 032M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Apr-2021, the patient experienced NECK PAIN (pain in neck, shoulders and back), ARTHRALGIA (pain in neck, shoulders and back) and BACK PAIN (pain in neck, shoulders and back). At the time of the report, NECK PAIN (pain in neck, shoulders and back), ARTHRALGIA (pain in neck, shoulders and back) and BACK PAIN (pain in neck, shoulders and back) outcome was unknown. Not Provided          Most recent FOLLOW-UP information incorporated above includes: On 12-May-2021: Non-significant follow up on 13-May-2021
Urticaria without angioedema, coughing, wheezing, or difficulty breathing; Began 1-2 hours after vaccine given. Unknown duration as patient was called to follow up on, and mother did not return call.
Case number PHEH2014US020741, is an initial spontaneous report received from a nurse on 13 OCT 2014. This report refers to an 87 year old male patient. His medical history and concomitant medication was not reported. He was vaccinated with FLUVIRIN 2014/2015 (batch number: 1413201A) 0.5 ml intramuscular on 03 OCT 2014 (6 days later than supposed to get). Nurse stated that the person who opened the cooler stated the gel packs were still mushy, but temperature unknown. No adverse event was reported. No further information was provided.
pt recv vax & w/in 6 to 12hr devel fever, chills, sweating & severe h/a;returned to ER dx serum sickness made;tx w/corticosteroid;sever h/a, nausea, fever & chills;health professionals suspect slow rxn of anaphylaxis;
Menveo and Bexsero vaccine was given IM at two separate arms. the patient started to feel weak and leaned forward to her mom while sitting on the bed.  she laid down the bed and fainted for less than 5 seconds. her vital signs were normal after fainting except her HR around 130s. she vomited 1x and was nauseated a few minutes after fainting. she recovered completely 20 minutes later. she was coherent and alert after recovering from the fainting . she has no recollection that she fainted. EKG was normal. she was sent ome on stable condition
faint; This case was reported by a other health professional via sales rep and described the occurrence of faint in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, unknown after receiving Shingrix, the patient experienced faint (serious criteria GSK medically significant). On an unknown date, the outcome of the faint was unknown.   It was unknown if the reporter considered the faint to be related to Shingrix.  Additional case details were reported as follows: The age at vaccination was not reported. The age group was not reported but was captured as an adult as per the vaccine indication. The patient fainted after receiving Shingrix. No other details on events were reported. This case was 1 of 2 cases reported by the same reporter.
Started the day after the vaccine with fever, chills, fatigue.  Seen in the office on 4/21 and no longer with fever, but still with chills and fatigue.  Normal exam and negative for COVID (PCR test), Influenza A or B and RSV.  Told to observe as it may be due to the vaccine.  Seen again on 4/25 with worsening of the fatigue and c/o body aches overall and c/o her legs feeling heavy with difficulty lifting them and some struggle on the stairs.  No shortness of breath noted.  On exam, all was normal including her muscle tone.  Work up in progress for EBV, LFTs, CRP, ESR, ASO and ANA titers.  Discussed with patient about this possibly being early Guiane-Barre syndrome.  Also concerns about a possible viral etiology. but w/u still in progress
The nurse injected the shot incorrectly into my left arm.  I immediately got a sharp pain in my arm. I could not move my left arm.  And I still can not put pressure on my left  arm nor can I lift anything heavier than 10 pounds with my left arm.  As a result of the shot, I got fluid in my shoulder and my muscle. I had x rays, a MRI, cortisone shot and 14 physical therapy treatments thus far.
Ringing in ears started approximately 40 minutes after the shot.  Twice since the second shot, my ears have clogged up.  The excessive ringing still persists.
About 12 hours after the shot, I had significant chills, body aches, fever, severe nausea that induced vomiting (unable to keep down water). 12 hours then after these symptoms is when things began to slowly subside.  Just ended up missing work for two days.
Felt cold; Had a temperature; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (Felt cold) and PYREXIA (Had a temperature) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013m20a) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure.    On 09-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced NASOPHARYNGITIS (Felt cold) and PYREXIA (Had a temperature). At the time of the report, NASOPHARYNGITIS (Felt cold) and PYREXIA (Had a temperature) outcome was unknown.            No relevant concomitant medications were reported. No treatment information was provided.  Upon internal review on 21-May-2021, the age was corrected to unknown.
Swollen left lymph node; Fatigue; Chills; Minor headache; Minor stomach ache; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 28Feb2021 at 12:45 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history. The patient had no known allergies. The patient did not receive any concomitant medications. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 07Feb2021 at 12:45 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. On 01Mar2021 at 09:30, the patient experienced swollen left lymph node, fatigue, chills 24 hours after shot, minor headache and minor stomach ache. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events swollen left lymph node, fatigue, chills, minor headache, and minor stomach ache were resolving at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
No adverse symptoms reported; "inadvertently administered and expired dose of VAQTA; This spontaneous report was received from a nurse and refers to a 17-year-old patient of unknown gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On 15-JAN-2020, the patient was inadvertently vaccinated with expired hepatitis a vaccine, inactivated (VAQTA) lot # R030115, expiration date 29-DEC-2019 (exct dose and route of administration were not reported) for prophylaxis. No adverse symptoms were reported.
Pt had a positive COVID test post mortem; pt passed away at home; no record of PCP
LITTLE HEADACHE; This spontaneous report received from a patient concerned an 82 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, and expiry: UNKNOWN) dose was not reported, administered on 05-APR-2021 12:05 for prophylactic vaccination. No concomitant medications were reported. On 06-APR-2021, the subject experienced little headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from little headache on 06-APR-2021. This report was non-serious.
Patient comes to the clinic today with a rash on her left arm.  She states that she got a Pneumovax in the office here four days ago.  Two days later she had fever and shaking chills.  Since then the area is warm swollen and red.  She also has body aches.  Now, the rash  is moving down the arm towards the elbow. She denies fever or chills today, SOB, no chest pains or pressures. Orders  Sulfamethoxazole-TMP DS 800-160 MG Tablet;TAKE 1 TABLET TWICE DAILY; Qty20; R0; Rx
SYNCOPE - Passed out 5 minutes after the vaccination. Recovered right away after less than a minute. No intervention or treatments done.
This case was reported by a consumer via call center representative and described the occurrence of crying in a 2-month-old female patient who received KINRIX. Co-suspect products included Rotavirus vaccine. On 5th January 2017, the patient received KINRIX and Rotavirus vaccine (oral). On 5th January 2017, less than a day after receiving KINRIX and Rotavirus vaccine, the patient experienced crying, fever, wrong vaccine administered and inappropriate age at vaccine administration. In January 2017, the outcome of the crying and fever were recovered/resolved. On an unknown date, the outcome of the wrong vaccine administered and inappropriate age at vaccine administration were unknown. It was unknown if the reporter considered the crying and fever to be related to KINRIX and Rotavirus vaccine. Additional details were provided as follows: The patient's birth weight was 6lbs 4ozs and sibling number was 3. The patient received KINRIX (on thigh) by mistakenly instead of INFANRIX at an age of 2 months, which led to an administration of wrong vaccine and an inappropriate age at vaccine administration. The patient also received 2 other immunization injection vaccines and the oral rotavirus vaccine at the same appointment. The names of those vaccines were not known. The patient cried for hours after vaccination and developed a low grade fever that resolved with fever reducer medication.
High-pitched cry and body stiffening lasting several hours.  Arm held out or overhead several episodes of shuddering followed.  NO fever fully recovered following day.
Since 18 December she has complained of recurrent episodes of localized itching and rashes described as flat and raised, red, itchy ?spots? which can occur on her torso, arms, and legs which worsens where her skin is scraped or scratched. Lesions last less than 24 hours, spare her palms and soles, and resolve without post-inflammatory changes. She denies generalized cutaneous, laryngeal, pulmonary, GI/GU, neurologic, and cardiovascular symptoms with these episodes. Episodes not associated with exercise, sweating, cold, foods, medications, NSAIDs, IV contrast, latex exposure, infections, or insect bites/stings. Possible association with heat. She received her Moderna COVID-19 vaccine booster dose on 8 December, 10 days prior to onset of symptoms. She has used oral antihistamines with only limited benefit. She denies constitutional symptoms. UCT score today is 14 (1, 2, 2, 3, 2, 1, 1, 2). She feels that her symptoms are gradually improving.
On 12/31/2020 patient came to clinic to get her 2nd Pfizer COVID vaccine.  Employee did not bring her vaccination card.   RN gave the injection at 12:35 in the left deltoid.  After giving the vaccine realized that the employee had her 1st dose of the Pfizer Covid vaccine on12/16/2020 and should not have had 2nd dose until between 1/2/2021- 1/10/2021
Patient called pharmacy 8-28-2017 stating that she has been experiencing severe dizziness, nausea & vomiting since she received the vaccine on the 22nd of August and that the symptoms were the worst on 8-27-2017. She also states that the injection site and surrounding area feel "Hot" but there is no redness or any changes in appearance. She stated that she went to emergency room but left before being seen by any medical professional. She is following up with her PCP in a month.
Itching at the shot site.  The site is swollen and slightly warm to touch. 10 days later swollen lymph nod under the shot arm .  Slight faint headache and chills.  Runny nose, sneezing, and felling tired.
Patient admitted on 2/21/21 and died in hospital on 2/22/2021.  Patient had a significant, lifelong  underlying medical condition.
DIAGNOSED WITH COVID 1/21/21; RECIEVED BAMLANIVUBAM INFUSION; HOSPITAL ADMISSION 1/23/21 WITH ACUT RESPIRATORY FAILURE DUE TO COVID. INTUBATED X 10 DAYS
Thursday April 8, 8:15pm arm starts to ache; 8:30pm feel a little nauseous; 11:30pm feel dizzy (like the bed is moving under me) while I'm laying down. Friday April 9: 5:20am headache, body aches, nausea and fatigue; stayed in bed. 4:15pm went out to feed the cats and felt dizzy and kept loosing my balance; 5:30pm feel bad again: dizzy, headache and exhausted; That night my head ached and I felt mildly unwell. Saturday April 10: I feel better all around but I'm still getting dizzy and loosing my balance; also I still have a slight head ache. By 11:00 am, I'm feeling much better - just about normal.
no adverse effects reported; Product storage error; This spontaneous report was received from a nurse referring to a patient of unknown age and gender.  The patient's concurrent conditions, medical history and concomitant medications were not reported.  Since an unknown date, the following lot# of varicella virus vaccine live (Oka/Merck) (VARIVAX) were improperly stored between 15 degrees Fahrenheit and 46 degrees Fahrenheit (mainly at 39.7 degrees Fahrenheit) for 2 hours and 20 minutes. Lot# R034391 (expiration date: 27-NOV-2020), lot# S005082 (has been verified to be a valid lot number for varicella virus vaccine live (Oka/Merck), expiration date reported as 28-FEB-2021, but upon internal validation established as 19-FEB-2021) and lot# S000132 (expiration date: 02-JAN-2021). On 05-JUL-2019, the patient was vaccinated with varicella virus vaccine live (Oka/Merck) (VARIVAX) (dose, frequency and route not reported) for prophylaxis. The nurse was not sure with which of the improperly stored varicella virus vaccine live (Oka/Merck) (VARIVAX) lot numbers was administered to the patient. No previous temperature of excursion was reported. A digital data logger was involved. No adverse effects were reported.; Sender's Comments:  US-009507513-1907USA004327: US-009507513-1907USA004328: US-009507513-1907USA004242:
2 weeks after injection in shoulder area pain is being reported. Patient states she is having difficulty lifting and using the arm.
My tinnitus, that I have had for at least 10 years and which had not had any noticeable change in intensity or sound, became louder and included new pitches; BNT162B2 was administered before 19 days of primary dose; This is a spontaneous report from a contactable reporter (consumer or other non-HCP). The reporter is the patient.  A 70-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 15May2021 (Lot number: EW0167) at the age of 70 years as dose 2, single for COVID-19 immunisation. Relevant medical history included: "COVID-19" (unspecified if ongoing), notes: Prior to vaccination, was the patient diagnosed with COVID-19: Yes and "Tinnitus" (ongoing), notes: My tinnitus, that I have had for at least 10 years. There were no concomitant medications. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE; Lot number: EW0164; Anatomical site: Right arm; Route of administration: unspecified), administration date: 29Apr2021, when the patient was 70 years old, for COVID-19 immunisation.  The following information was reported: INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (non-serious) with onset 15May2021, outcome "unknown", described as "BNT162B2 was administered before 19 days of primary dose"; TINNITUS (non-serious) with onset 01Jun2021, outcome "not recovered", described as "My tinnitus, that I have had for at least 10 years and which had not had any noticeable change in intensity or sound, became louder and included new pitches". Therapeutic measures were not taken as a result of tinnitus.  Additional information: The patient had no known allergies. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. It was reported that the change persisted to the present day. The patient was nervous about getting the booster shot as a result. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19.
I started with normal flu like symptoms for 3 days. Then after that I started having pain that seemed similar to a toothache/ear infection. As time went on it was getting worse and worse. I thought it was an ear infection and that it would go away on its own. On the week of 5/03/2021 it started becoming unbearable. I made an appointment to see the doctor to check out my ear. While at work on 5/10/2021 I started feeling like my blinking was off. I felt like my left side was slow and weak. By bedtime I was struggling to spit. I knew I had a doctor appointment in the morning so I decided to wait it out. By the time I got to my appointment most of the left side of my face was weak and not working properly. I also have severe pain in my ear and my jaw. I was diagnosed with Bells Palsy at the doctors office. He believes it is vaccine related. He gave me medication and suggested that I report this. He says that he expects a full recovery and very few people have permanent damage from this.
Fever 103, twitching Friday night with fever-possible seizure? lethargy, refusing to walk.
Visit 4/29/2021 Patient is a 27-year-old male comes in today with a recent Covid vaccination, Pfizer 4/20/2021. Patient was originally seen 7 days ago for symptoms of shortness of breath and high anxiety after having the vaccination. Since that time, patient has been doping his own research and feels that his is having an adverse reaction to the vaccine. He is complaining of 4 days of CP intermittent dull and tightness in nature, lasting < 1 min up to 30 times daily, Chest discomfort last throughout the day, nothing makes it worse or better, which also increases his anxiety and to panic.   Visit on 4/21/2021 Patient states that after he received the vaccination he had some brief interval of shortness of breath, high anxiety that lasted approximately 30 seconds to 1 minute and then resolved. Patient scared that he was having an allergic reaction.  Patient denies any other symptoms, SOB, wheezing, coughing, chest pain, nausea, vomiting,diarrhea, redness to site or red streaking, enlarge lymph nodes. All sx. resolved same day
after the 1st dose had a stroke; This is a spontaneous report from a non contactable consumer (Patient's wife)  A male patient of an unspecified age received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration on Mar2021 (Batch/Lot number was not reported) as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient after the 1st dose had a stroke (medically significant) on an unspecified date with outcome of unknown.   No follow-up attempts are possible. No further information is expected.
Listlessness; Sore arm; Headache; One day of tiredness; This spontaneous case was reported by a consumer and describes the occurrence of LISTLESS (Listlessness), PAIN IN EXTREMITY (Sore arm), HEADACHE (Headache) and FATIGUE (One day of tiredness) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced LISTLESS (Listlessness), PAIN IN EXTREMITY (Sore arm), HEADACHE (Headache) and FATIGUE (One day of tiredness). At the time of the report, LISTLESS (Listlessness), PAIN IN EXTREMITY (Sore arm) and HEADACHE (Headache) outcome was unknown and FATIGUE (One day of tiredness) had resolved.            No concomitant medication information was provided.  No treatment medications were provided.   This case was linked to MOD-2022-490560, MOD-2022-456385 (Patient Link).
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a patient of unknown age and gender. Information was provided regarding concomitant medications, concurrent conditions or medical history. In 2010, the patient was inoculated with ZOSTAVAX at the county public health as recommended for routine adult health maintenance for the prevention of shingles (dose, route, and lot # not provided). The vaccine did not prevent shingles as intended and the patient subsequently contracted a persistent strain condition of herpes zoster or shingles. In 2016, the patient was treated by the physician for a blistering vesicular outbreak, which was diagnosed as severe herpes zoster or shingles. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown. Causality assessment was related. Additional information has been requested.
No adverse symptoms were reported in the patient; A patient received a dose of PROQUAD following a temperature excursion; Information has been received from a nurse regarding a patient of unknown age and gender. The patient's medical history, drug allergies, previously drug reactions, concurrent conditions and concomitant medications were not reported.  On an unknown date, the patient was vaccinated with improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live recombinant human albumin (rHA) (PROQUAD) as prophylaxis, (lot number S017239 with expiration date in 01-DEC-2020 which was reconstituted with properly stored sterile diluent (MERCK STERILE DILUENT) (route of administration, strength and anatomical location not reported).  On 04-DEC-2019, the mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) was stored at a temperature range of 15 degrees Fahrenheit (°F) to 46 °F (-9°C to 8°C) (16.2F) for the time frame of 1 hour 30 minutes. There was no previous temperature excursion and the call was because of a data logger.  No adverse effects reported.